What does single reportable segment — income taxes mean?

This metric represents the total tax expense accrued or paid to government authorities based on the company's taxable income. It reflects the company's tax burden and is influenced by jurisdictional tax laws and the company's overall profitability. Monitoring this is essential for understanding the net earnings available to shareholders.

Rhythm Pharmaceuticals, Inc. RYTM Single reportable segment — Income taxes

Similar metrics at other companies

FIVEReportable Segment — Income Tax

$39.44M+157%

PYPLReportable Segment — Income Tax

$280M-11.4%

CELHReportable Segment — Income Tax Expense (Benefit)

$27.44M+65.5%

UNPReportable Segment — Income Tax

$528M+5.4%

PTGXSingle Reportable — Income Tax Expense Benefit

-$1.5M—

NSCReportable Segment — Income taxes

$168M-26.3%

Other financials

Income statement

See full

Revenue$60.1M+83.8%

Gross profit$53.0M+82.3%

Operating income-$52.4M-11.4%

Net income-$55.6M-12.4%

EPS (diluted)-$0.83-2.5%

Balance sheet

See full

Cash & equivalents$62.1M-41.4%

Total debt$112.3M-1.1%

Total equity$122.9M+549%

Total assets$442.3M+14.4%

Cash flow

See full

Operating cash flow-$44.2M-9.5%

CapEx$238.3K—

Free cash flow-$29.2M-2.4%

Valuation

See full

Market cap$6.64B+77.3%

Enterprise value$6.69B+78.4%

P/S30.6×+3.2×

Profitability

See full

Gross margin89.4%-0.2pp

Operating margin-90.9%-19.8pp

Net margin-93.3%-18.2pp

FCF margin-61.5%-14.1pp

Returns & leverage

See full

Return on equity-285.8%-68.9pp

Debt / equity0.9×-5.1×

Current ratio4.2×+0.9×

Where this comes from

Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rhythm Pharmaceuticals, Inc.'s single reportable segment — income taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rhythm Pharmaceuticals, Inc.'s single reportable segment — income taxes?: Rhythm Pharmaceuticals, Inc. (RYTM) reported single reportable segment — income taxes of $545K in Q1 2026.
What does single reportable segment — income taxes mean?: This metric represents the total tax expense accrued or paid to government authorities based on the company's taxable income. It reflects the company's tax burden and is influenced by jurisdictional tax laws and the company's overall profitability. Monitoring this is essential for understanding the net earnings available to shareholders.